| scholarly article | Q13442814 |
| P50 | author | Bronwen Connor | Q89412931 |
| Ruth Monk | Q124392033 | ||
| P2093 | author name string | Kevin Lee | |
| Carsten Rudolph | |||
| Johannes Geiger | |||
| Kathryn Jones | |||
| Sophie Liot | |||
| Amy McCaughey-Chapman | |||
| Erin Firmin | |||
| P2860 | cites work | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA | Q24316383 |
| Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 | ||
| Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | Q26269888 | ||
| Induction of human neuronal cells by defined transcription factors | Q26269896 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| 5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
| Vertebrate neurogenesis is counteracted by Sox1-3 activity | Q28205692 | ||
| Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells | Q28475963 | ||
| Six3 controls the neural progenitor status in the murine CNS | Q28507238 | ||
| Genomic code for Sox2 binding uncovers its regulatory role in Six3 activation in the forebrain. | Q44558209 | ||
| Generation of mouse-induced pluripotent stem cells with plasmid vectors | Q45013661 | ||
| Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease. | Q45305684 | ||
| Expression of therapeutic proteins after delivery of chemically modified mRNA in mice | Q45866149 | ||
| Rapid and Efficient Direct Conversion of Human Adult Somatic Cells into Neural Stem Cells by HMGA2/let-7b | Q48369952 | ||
| Zic3 induces conversion of human fibroblasts to stable neural progenitor-like cells | Q56777673 | ||
| New approaches for brain repair—from rescue to reprogramming | Q59070234 | ||
| Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a | Q59758209 | ||
| Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. | Q64937041 | ||
| Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency | Q83787226 | ||
| The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis | Q28590512 | ||
| Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 | ||
| Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 | ||
| Activation of neural cell fate programs toward direct conversion of adult human fibroblasts into tri-potent neural progenitors using OCT-4. | Q30585772 | ||
| Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs | Q33806734 | ||
| SOX2 functions to maintain neural progenitor identity | Q33968061 | ||
| Pax6 is a human neuroectoderm cell fate determinant | Q33996031 | ||
| Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions | Q34031759 | ||
| Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation | Q34146278 | ||
| Direct reprogramming of mouse fibroblasts to neural progenitors | Q34180572 | ||
| Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 | ||
| Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 | ||
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor | Q34280164 | ||
| Non-viral vectors for gene-based therapy | Q34429032 | ||
| Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming | Q34575700 | ||
| Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors | Q35180600 | ||
| Probing disorders of the nervous system using reprogramming approaches | Q35761135 | ||
| SOX genes and neural progenitor identity | Q36049176 | ||
| Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors | Q36212351 | ||
| Generation of integration-free and region-specific neural progenitors from primate fibroblasts | Q37205314 | ||
| Current prospects for mRNA gene delivery | Q37307200 | ||
| Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability | Q37416925 | ||
| Direct Conversion of Human Fibroblasts into Neural Progenitors Using Transcription Factors Enriched in Human ESC-Derived Neural Progenitors | Q37583579 | ||
| Methods for making induced pluripotent stem cells: reprogramming à la carte | Q37845645 | ||
| Synthetic mRNAs with superior translation and stability properties. | Q38072371 | ||
| Concise review: the involvement of SOX2 in direct reprogramming of induced neural stem/precursor cells | Q38118544 | ||
| RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. | Q38121503 | ||
| Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells | Q38462208 | ||
| Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience | Q38838046 | ||
| Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4. | Q38875265 | ||
| Understanding Parkinson's Disease through the Use of Cell Reprogramming | Q39085008 | ||
| Wnt3a regulates survival, expansion, and maintenance of neural progenitors derived from human embryonic stem cells | Q40083924 | ||
| Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts | Q40485394 | ||
| Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors | Q40813551 | ||
| In Vitro Differentiation of Human Neural Progenitor Cells Into Striatal GABAergic Neurons. | Q40942034 | ||
| Retinoic acid mediates Pax6 expression during in vitro differentiation of embryonic stem cells | Q41058233 | ||
| Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts | Q41902835 | ||
| Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes | Q42714345 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e00918 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Heliyon | Q27727019 |
| P1476 | title | Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA | |
| P478 | volume | 4 |
Search more.